OAM
SCMP

Oxford Asset Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Oxford Asset Management’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-416,146
Closed -$7.48M – 2067
2017
Q4 		$7.48M Buy
416,146
+187,447
+82% +$2.31M 0.16% 128
2017
Q3 		$2.71M Sell
228,699
-15,108
-6% -$169K 0.05% 460
2017
Q2 		$2.56M Buy
243,807
+41,384
+20% +$422K 0.05% 492
2017
Q1 		$2.23M Sell
202,423
-98,195
-33% -$1.14M 0.05% 426
2016
Q4 		$4.07M Buy
300,618
+37,032
+14% +$517K 0.14% 137
2016
Q3 		$3.25M Sell
263,586
-145,756
-36% -$1.72M 0.1% 270
2016
Q2 		$4.49M Buy
409,342
+87,158
+27% +$976K 0.15% 165
2016
Q1 		$3.52M Sell
322,184
-111,035
-26% -$1.4M 0.1% 255
2015
Q4 		$7.67M Buy
433,219
+165,310
+62% +$2.96M 0.18% 112
2015
Q3 		$5.32M Buy
267,909
+37,585
+16% +$862K 0.17% 119
2015
Q2 		$3.78M Sell
230,324
-84,620
-27% -$1.47M 0.1% 221
2015
Q1 		$4.9M Buy
314,944
+18,291
+6% +$284K 0.12% 185
2014
Q4 		$4.35M Buy
+296,653
New +$3.13M 0.1% 230

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Oxford Asset Management's SCMP Position: Q1 2018 in Review

Oxford Asset Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 416,146 shares — an estimated $7.48M sold.

Oxford Asset Management first reported a position in SCMP in Q4 2014 and held it in 13 quarters. The position peaked at $7.67M in Q4 2015. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Oxford Asset Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Oxford Asset Management sold 416,146 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $7.48M.
  • Oxford Asset Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2014 and held it in 13 quarters.
  • Oxford Asset Management's Sucampo Pharmaceuticals, Inc. position peaked at $7.67M in Q4 2015.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Oxford Asset Management's 13F filing for Q1 2018, filed 15 May 2018.